1. Home
  2. PRAX vs PFBC Comparison

PRAX vs PFBC Comparison

Compare PRAX & PFBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRAX
  • PFBC
  • Stock Information
  • Founded
  • PRAX 2015
  • PFBC 1991
  • Country
  • PRAX United States
  • PFBC United States
  • Employees
  • PRAX N/A
  • PFBC N/A
  • Industry
  • PRAX Biotechnology: Pharmaceutical Preparations
  • PFBC Major Banks
  • Sector
  • PRAX Health Care
  • PFBC Finance
  • Exchange
  • PRAX Nasdaq
  • PFBC Nasdaq
  • Market Cap
  • PRAX 952.1M
  • PFBC 1.1B
  • IPO Year
  • PRAX 2020
  • PFBC 1998
  • Fundamental
  • Price
  • PRAX $52.00
  • PFBC $90.56
  • Analyst Decision
  • PRAX Strong Buy
  • PFBC Hold
  • Analyst Count
  • PRAX 10
  • PFBC 3
  • Target Price
  • PRAX $93.30
  • PFBC $103.67
  • AVG Volume (30 Days)
  • PRAX 435.3K
  • PFBC 80.9K
  • Earning Date
  • PRAX 11-05-2025
  • PFBC 10-20-2025
  • Dividend Yield
  • PRAX N/A
  • PFBC 3.32%
  • EPS Growth
  • PRAX N/A
  • PFBC N/A
  • EPS
  • PRAX N/A
  • PFBC 9.51
  • Revenue
  • PRAX $7,765,000.00
  • PFBC $267,978,999.00
  • Revenue This Year
  • PRAX N/A
  • PFBC $2.56
  • Revenue Next Year
  • PRAX $20.00
  • PFBC $3.42
  • P/E Ratio
  • PRAX N/A
  • PFBC $9.51
  • Revenue Growth
  • PRAX 338.45
  • PFBC 1.62
  • 52 Week Low
  • PRAX $26.70
  • PFBC $71.90
  • 52 Week High
  • PRAX $91.83
  • PFBC $99.78
  • Technical
  • Relative Strength Index (RSI)
  • PRAX 56.68
  • PFBC 43.32
  • Support Level
  • PRAX $46.99
  • PFBC $89.07
  • Resistance Level
  • PRAX $55.86
  • PFBC $92.61
  • Average True Range (ATR)
  • PRAX 3.62
  • PFBC 1.69
  • MACD
  • PRAX 0.56
  • PFBC -0.18
  • Stochastic Oscillator
  • PRAX 74.41
  • PFBC 24.79

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

About PFBC Preferred Bank

Preferred Bank is a commercial bank located in California. Its products and services are divided into Personal Banking, Business Banking, and Commercial Banking which includes Checking accounts, Savings accounts, CDs, Loans and Credit, Electronic banking, and Treasury Management. It provides personalized deposit services, real estate finance, commercial loans, and trade finance credit facilities to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals, and high-net-worth individuals. The bank generates a majority of its revenue from Southern and Northern California and Flushing.

Share on Social Networks: